National clinical trials – here at home
Cancer research never stops
With new breakthroughs being made nearly every day; such discoveries aren't just being made in major metropolitan hospitals far from Kansas. They're being made in clinical trials conducted at the Via Christi Cancer Institute.
Via Christi Cancer Institute manages the grant funding for Wichita Community Clinical Oncology Program (CCOP), which brings the latest cancer research to Kansas. Known as Wichita CCOP, it's one of 63 programs sponsored and funded by the National Cancer Institute.
Care close to home
Through relationships with such well-known programs as the M.D. Anderson Cancer Center in Houston and Mayo Clinic in Rochester, MN, and participating physicians nationwide, the Wichita CCOP offers patients the most current cancer research in detection, diagnosis, treatment, prevention, control and quality of life.
And you don't have to travel to Houston or Rochester to receive that high-quality care.
When a new cancer procedure or treatment is found, clinical trials are conducted to determine their effectiveness. When you participate in a treatment or cancer control clinical trial, you may have the opportunity to receive a new drug or drug combination.
The hope is that the new treatments will be an improvement over the therapy currently accepted as the standard for your cancer care. With participation in cancer clinical trials, you are assured you will receive the best possible care. Since 1983, more than 12,000 patients have participated in Wichita CCOP trials.
Currently, Wichita CCOP is conducting trials targeting the following types of cancers::
- Bone marrow transplant: lymphoma, myeloma
- Brain: malignant gliomas, anaplastic astrocytomas, oligodendroglioma, medulloblastoma
- Breast: DCIS, preoperative chemotherapy followed by surgery,
Stage I, II, III and IV
- Cancer control: Studies for prevention of cancer and to manage symptoms such as weight loss, nausea, fatigue, pain control
- Gastrointestinal: colorectal, esophagus, pancreas, stomach
- Gynecology: cervical, ovarian, endometrial
- Head and Neck: cancer of larynx, oral cavity, oropharynx, hypopharynx
- Leukemia: ALL, AML, CLL, APL, cytogenetics
- Lung: non-small cell and small cell, Mesothelioma
- Lymphoma: non-Hodgkin's, Mantle cell, Hodgkin's, gastric malt, CNS lymphoma
- Melanoma: adjuvant, metastatic
- Multiple myeloma: Waldenstrom's & Multiple Myeloma
- Sarcoma: soft tissue
- Urinary: bladder, prostate, renal
In May 2011, Wichita CCOP was honored by Southwest Oncology Group for being its highest accruing Community Clinical Oncology Program in 2010.